luminal a breast cancer cell lines mcf 7 (ATCC)
99
Structured Review
ATCC
luminal a breast cancer cell lines mcf 7
Luminal A Breast Cancer Cell Lines Mcf 7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 34860 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luminal+breast+cancer+cell+lines+mcf+7/MCF7/pm41713536-215-10-25
Average 99 stars, based on 34860 article reviews
Luminal A Breast Cancer Cell Lines Mcf 7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 34860 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luminal+breast+cancer+cell+lines+mcf+7/MCF7/pm41713536-215-10-25
Average 99 stars, based on 34860 article reviews
luminal a breast cancer cell lines mcf 7 - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
other:Article Title: Construction and validation of acetylation-related gene signatures for immune landscape analysis and prognostication risk prediction in luminal breast cancer. Article Snippet: The luminal breast cancer cell lines MCF-7 and Article Title: Construction and validation of acetylation-related gene signatures for immune landscape analysis and prognostication risk prediction in luminal breast cancer Article Snippet: The luminal breast cancer cell lines MCF-7 and Article Title: Enrichment of CD44+/CD24+ cells predicts chemoresistance in luminal breast cancer Article Snippet: Article Title: Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer Article Snippet: The human Multiple Displacement Amplification:Article Title: Salvia chinensis Benth Inhibits Triple-Negative Breast Cancer Progression by Inducing the DNA Damage Pathway Article Snippet: .. The human TNBC cell lines MDA-MB-231 and HCC1187, the human mammary epithelial cell line MCF-10A, the mouse TNBC cell line 4T1, the human luminal breast cancer cell lines MCF-7 and T47D, and the human HER2-positive breast cancer cell lines HCC1954 and Article Title: Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL/MET. Article Snippet: The following immunoblotting antibodies were used: phospho-AXL (Y702) #5724, phospho-MET (Y1234/1235) #3077, MET #8198, β-actin #4970, phospho-AKT (S473) #4060, AKT #4691, phospho-IκBα #2859, IκBα #4812, phospho-P65 #3033, Lamin B1 #13435, E-cadherin #3195, Vimentin #5741, TCF-ZEB1 #3396, Snail #3879, Slug #9585 and Poly(ADP-ribose) polymerase (PARP) #9542, purchased from Cell Signaling Technology (Beverley, MA, USA); AXL #20741, purchased from Santa Cruz (Santa Cruz, CA, USA); P65 #16502, purchased from Abcam (Cambridge, MA, USA); GAS6 #13795-1-AP, HGF #26881-1-AP, AXL #13196-1-AP, purchased from Proteintech (Wuhan, Hubei, china); and horseradish peroxidase (HRP)-conjugated secondary antibodies #AP-132P, purchased from Merck Millipore (Darmstadt, Germany). .. The basal-like/TNBC cell lines MDA-MB-231 and HS-578T and the luminal breast cancer cell lines MCF-7 and Article Title: Salvia chinensis Benth Inhibits Triple-Negative Breast Cancer Progression by Inducing the DNA Damage Pathway. Article Snippet: .. The human TNBC cell lines MDA-MB-231 and HCC1187, the human mammary epithelial cell line MCF-10A, the mouse TNBC cell line 4T1, the human luminal breast cancer cell lines MCF-7 and T47D, and the human HER2-positive breast cancer cell lines HCC1954 and |